We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| UnitedHealth Group Inc | NYSE:UNH | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 1.93 | 0.39% | 494.38 | 494.87 | 491.86 | 492.48 | 2,029,505 | 01:00:00 |
From May 2019 to May 2024
By Colin Kellaher
Shares of Inspire Medical Systems Inc. (INSP) rose more than 5% on Monday after the medical-technology company said health insurer UnitedHealthcare will provide coverage for the company's therapy, effective Aug. 1.
Inspire said UnitedHealthcare, a unit of UnitedHealth Group Inc. (UNH), considers the company's hypoglossal nerve neurostimulation device to be medically necessary for the treatment of moderate to severe obstructive sleep apnea when specified criteria are met.
The Golden Valley, Minn., company said it now has 35 coverage policies representing about 125 million members that cover the Inspire therapy, compared with 3 million members a year ago.
Analysts at SVB Leerink said the UnitedHealthcare decision is "a big incremental positive" for Inspire, adding that they believe the company "is nearing a reimbursement 'tipping point' that should lead to accelerated adoption of its technology."
Shares of Inspire were recently up 6.9% to $68.28.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
July 08, 2019 11:22 ET (15:22 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year UnitedHealth Chart |
1 Month UnitedHealth Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
